Results 171 to 180 of about 3,539,187 (313)
Clinical impact of genetic testing in inherited kidney diseases. [PDF]
Merz LM +19 more
europepmc +1 more source
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci +25 more
wiley +1 more source
Mitophagy and Cellular Homeostasis in Kidney Diseases: Mechanisms and Potential Therapeutics. [PDF]
Lu H +11 more
europepmc +1 more source
Objective Gastrointestinal (GI) involvement can lead to malnutrition in patients with systemic sclerosis (SSc). Body mass index (BMI) remains the most widely used marker to screen nutritional status. We aimed to identify predictors of lower BMI in patients with SSc. Methods Patients with SSc from a prospective US cohort meeting 2013 American College of
Ali Y. Ayla +8 more
wiley +1 more source
Ketone bodies in kidney diseases: novel insights. [PDF]
Dai W +6 more
europepmc +1 more source
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee +4 more
wiley +1 more source
The global role of kidney transplantation
World Kidney Day on March 8th 2012 provides a chance to reflect on the success of kidney transplantation as a therapy for endstage kidney disease that surpasses dialysis treatments both for the quality and quantity of life that it provides and for its ...
Chapman, J., Harden, P., Garcia, G.G.
core
Therapeutic potential and research progress of microecological agents in kidney diseases. [PDF]
Qian Y, Zhang C.
europepmc +1 more source
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram +25 more
wiley +1 more source
Lactylation in kidney diseases: a review of regulatory mechanisms and therapeutic prospects. [PDF]
Feng Y +11 more
europepmc +1 more source

